Our new State of Global Fermentation Report is here!
Download it for free via this link.

Critical insights to get your bioproduct to market.

Getting a bioproduct to market involves a lot of uncertainty. Scaler™ by Synonym is the first step in your commercialization journey.

Scaler™ is a next-gen techno-economic analysis for fermentation that helps you:

- Project your costs to build and operate at scale.

- Identify your biggest profitability drivers.

- Understand your levers of commercial adoption.

Get Started
Scaler™ is currently in beta and capable of modeling aerobic, aseptic fermentation processes. Fall outside this segment? Contact us at [email protected] and tell us what segment to add next.

Curious how it works?

1

Get Started

Answer 10 initial questions to start building your base model.

The initial questions cover fermentation and commercial basics including:

  • Product Attributes
  • Process Specifics
  • Capacity Goals
  • Pricing Details

2

Generate Your Report

Produce your first report based on the initial 10 questions.

Your report provides a breakdown of factors impacting unit economics including:

  • Facility CapEx
  • Ongoing OpEx (COGS)
  • Financing Costs
  • Economies of Scale

3

Refine Your Results

Access 50+ parameters to generate a more customized report.

Enhance existing or create new models by completing advanced questions including:

  • Fermentation Parameters
  • Feedstock, Media and Consumables
  • Downstream Processing
  • Economic and Financing Assumptions

Make smarter decisions and understand the metrics that impact your ability to scale.

Learn why our users love Scaler...

Arturo Elizondo

CEO, The EVERY Company

"Synonym's insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale."

Anne Palermo

CEO & Co-Founder, Aqua Cultured Foods

"By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability."

Friederike Grosse-Holz

Director, Blue Horizon

"It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS."

 

Harness the power of an accessible, purpose-built techno-economic analysis.

Techno-economic analyses (TEAs) provide a systematic and rigorous evaluation of the economic viability of a technology. TEAs are key resources that help businesses inform decision making to maximize upside and minimize potential costs and risks. Despite their importance, robust TEAs remain out of reach for many companies because they require specialized expertise and are costly to build.

Scaler™ by Synonym is a free, next-gen techno-economic modeling tool designed specifically for the bioeconomy. It can simulate the economic performance of many fermentation processes in industrial scale settings and help you build a realistic commercialization roadmap.

Have questions?

What is Scaler™?

Scaler™ is a techno-economic analysis (TEA) designed specifically for the bioeconomy. It can simulate the economic performance of many fermentation processes in industrial scale settings.

Who should use Scaler™?

Scaler™ is for everyone! Whether you’re a startup developing a new bioproduct, a Fortune 1000 company buying a bioproduct, or a venture capital firm considering an investment in a synbio company, Scaler can help you understand the economic impact of your decisions.

Does it cost money to use Scaler™?

No — Scaler™ is currently free to use with up to 10 runs per day allowed per user.

Why are techno-economic analyses (TEAs) important?

TEAs provide a systematic and rigorous evaluation of the economic viability of a technology, and inform decision-making to maximize upside and minimize potential costs and risks.

Didn’t find the answer to your question?

Reach out to our team at [email protected] and we will be in touch.